Case Report: Infusion-Related Reactions to Intravenous Infliximab and Subcutaneous Ustekinumab in Pediatric Crohn's Disease

Background: Although the biological agent ustekinumab (UST) is reported to be effective for Crohn's disease (CD) in pediatric as well as adult patients, data on the efficacy and safety of UST in pediatric patients with CD are limited. Here, we describe the case of a pediatric patient who showed...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakiuchi, Toshihiko, Kimura, Sakiko, Esaki, Motohiro, Matsuo, Muneaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739802/
https://www.ncbi.nlm.nih.gov/pubmed/35004530
http://dx.doi.org/10.3389/fped.2021.670703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739802/
https://www.ncbi.nlm.nih.gov/pubmed/35004530
http://dx.doi.org/10.3389/fped.2021.670703

Ejemplares similares